Stroke Trial, Recruiting NCT03869138 Sponsor: University of Illinois at Chicago Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT03869138
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 18 and 90 years of age.
  • People who are able to understand and follow instructions given in English.
  • People who have been diagnosed with a neurological condition — specifically stroke, Parkinson's disease, or Multiple Sclerosis — for at least 6 months before the assessment (confirmed by their doctor).
  • People who are able to stand and walk as part of their daily life, with or without a walking aid or braces.
  • People who have sufficient thinking and memory skills to actively take part, as measured by a standard cognitive assessment test.
  • People who have had a stroke and have a minimum level of arm and shoulder muscle function, as measured by specific clinical tests (confirm with trial site for exact score requirements).
  • People with Parkinson's disease who are on a stable medication routine, are in an early stage of the condition (Stage I or II by the Boher classification), and do not experience sudden "on-off" fluctuations in their symptoms.
  • People with Multiple Sclerosis who do not have severe disability, as measured by a standard disability scale (EDSS score of 4.5 or below).

Who may not be able to join:

  • People with significant difficulties in thinking, memory, or communication, as measured by standard screening tests for cognitive impairment, aphasia (language difficulties), or depression.
  • People with serious current medical conditions, including unhealed pressure sores, active or untreated infections, blood clot disorders, severe joint stiffness, bone growths in the lower limbs, lower leg fractures, known nerve injury in the lower legs, heart or lung complications, a pacemaker, or kidney or liver problems, or uncontrolled seizures.
  • People who have had a major heart, lung, muscle, bone, or whole-body health event in the past 6 months, a major surgery within the past 6 months, a hospital stay within the past 3 months, or who are currently taking sedative medications.
  • People who are not able to commit to 12 weeks of participation.
  • People who are currently receiving other treatments such as Botox injections, or who are taking part in another research study at the same time.
  • People who are pregnant.
  • People experiencing uncontrolled pain rated above 3 out of 10.
  • People who experience shortness of breath.
  • People with uncontrolled high blood pressure (resting systolic blood pressure above 165 mmHg and/or diastolic above 110 mmHg).
  • People whose resting heart rate is above 85% of their age-predicted maximum heart rate (confirm with trial site for calculation details).
  • People whose blood oxygen level at rest falls below 95%, as measured by a pulse oximeter.
  • People with severe heart disease (classified as Grade II to IV by the New York Heart Association scale).
  • For one specific test in the trial (the Laboratory Slip test only), people may not be able to take part in that particular test if they have low bone density (a T-score below -2 on a heel ultrasound), weigh more than 250 lbs or have a BMI above 35 kg/m², are unable to walk 8 metres twice (with a short rest in between) without a cane, or are unable to stand for at least 5 minutes without a significant drop in blood pressure. People excluded from this one test may still be eligible to participate in the rest of the study (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tanvi Bhatt, University of Illinois at Chicago

Phone: 7082910471

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Illinois at Chicago
Registry
ClinicalTrials.gov
Start date
9 September 2019
Est. completion
30 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Postural Stability; Compliance to therapy (total time spent over the intervention duration); Change in reaction time with functional arm reach

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov